DK404588A - Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents
Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelseInfo
- Publication number
- DK404588A DK404588A DK404588A DK404588A DK404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydrocabazole
- compound
- pharmaceutical preparation
- preparation containing
- alkanic acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/076,424 US4808608A (en) | 1986-01-23 | 1987-07-21 | Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK404588D0 DK404588D0 (da) | 1988-07-20 |
| DK404588A true DK404588A (da) | 1989-03-16 |
Family
ID=22131920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK404588A DK404588A (da) | 1987-07-21 | 1988-07-20 | Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4808608A (fr) |
| EP (1) | EP0300676A3 (fr) |
| JP (1) | JPS6470462A (fr) |
| KR (1) | KR890001987A (fr) |
| AU (1) | AU611454B2 (fr) |
| DK (1) | DK404588A (fr) |
| IL (1) | IL87079A0 (fr) |
| NZ (1) | NZ225361A (fr) |
| PT (1) | PT88044B (fr) |
| ZA (1) | ZA885209B (fr) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| US6300361B1 (en) * | 1990-07-25 | 2001-10-09 | Novartis Ag | Stabilized pharmaceutical compositions comprising acid donors |
| US5221678A (en) * | 1990-07-26 | 1993-06-22 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| US5187180A (en) * | 1990-07-26 | 1993-02-16 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| GB9101375D0 (en) * | 1991-01-22 | 1991-03-06 | Erba Carlo Spa | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
| US5230350A (en) * | 1991-05-29 | 1993-07-27 | Tabex Industries, Inc. | Moisture barrier for indwelling catheters and the like |
| DE4435477A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| US5830911A (en) * | 1996-08-14 | 1998-11-03 | American Home Products Corporation | Pyranoindole and tetrahydrocarbazole inhibitors of COX-2 |
| US20010047027A1 (en) * | 2000-04-12 | 2001-11-29 | Marc Labelle | Prostaglandin D2 receptor antagonists |
| US6410583B1 (en) * | 2000-07-25 | 2002-06-25 | Merck Frosst Canada & Co. | Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| US7217725B2 (en) * | 2000-09-14 | 2007-05-15 | Allergan, Inc. | Prostaglandin D2 antagonist |
| US7273883B2 (en) * | 2000-09-14 | 2007-09-25 | Allergan, Inc. | Prostaglandin EP4 antagonist |
| US7067148B2 (en) | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| AR038136A1 (es) | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
| WO2004039807A1 (fr) | 2002-10-30 | 2004-05-13 | Merck Frosst Canada & Co. | Pyridopyrrolizine et derives de pyridoindolizine |
| WO2004063156A1 (fr) * | 2003-01-08 | 2004-07-29 | Biovitrum Ab | Nouveaux derives d'indole utiles comme inhibiteurs de fabp-4 |
| AR041089A1 (es) * | 2003-05-15 | 2005-05-04 | Merck & Co Inc | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas |
| US20070054951A1 (en) * | 2003-05-20 | 2007-03-08 | Lianhai Li | Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| WO2004111047A2 (fr) * | 2003-06-12 | 2004-12-23 | Merck Frosst Canada Ltd. | Cycloalkanepyrrolopyridines utilisees comme antagonistes du recepteur dp |
| AU2004262970B2 (en) * | 2003-08-07 | 2010-03-18 | Merck Sharp & Dohme Limited | Treatment for Alzheimer's disease and related conditions |
| US7019022B2 (en) * | 2003-12-15 | 2006-03-28 | Merck Frosst Canada & Co. | Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| US7714132B2 (en) * | 2004-03-11 | 2010-05-11 | Actelion Pharmaceuticals, Ltd. | Tetrahydropyridoindole derivatives |
| CA2594280C (fr) | 2004-12-27 | 2013-04-23 | Anja Fecher | Derives de 2,3,4,9-tetrahydro-1h-carbazole utilises en tant qu'antagonistes des recepteurs de crth2 |
| WO2007047372A2 (fr) * | 2005-10-14 | 2007-04-26 | The Board Of Trustees Of The University Of Illinois | Traitements pharmacologiques contre des troubles du sommeil |
| ATE530523T1 (de) * | 2006-08-07 | 2011-11-15 | Actelion Pharmaceuticals Ltd | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate |
| EP2114154B1 (fr) * | 2007-02-08 | 2013-08-28 | Merck Sharp & Dohme Corp. | Procédé de traitement de l'athérosclérose, des dyslipidémies et d'états pathologiques apparentés |
| BRPI0807942A2 (pt) | 2007-02-16 | 2014-07-01 | Ono Pharmaceutical Co | Agente terapêutico para distúrbio de excreção urinária |
| AR080703A1 (es) | 2010-03-22 | 2012-05-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma. |
| DK2697223T3 (en) | 2011-04-14 | 2016-09-05 | Actelion Pharmaceuticals Ltd | 7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor |
| PE20161177A1 (es) | 2014-03-17 | 2016-11-18 | Actelion Pharmaceuticals Ltd | Derivados del acido acetico azaindol y su uso como moduladores del receptor de prostaglandina d2 |
| WO2015140701A1 (fr) | 2014-03-18 | 2015-09-24 | Actelion Pharmaceuticals Ltd | Dérivés d'acide aza-indol-acétique et leur utilisation comme modulateurs des récepteurs de la prostaglandine d2 |
| KR20180053345A (ko) | 2015-09-15 | 2018-05-21 | 이도르시아 파마슈티컬스 리미티드 | 결정질 형태 |
| JP7366057B2 (ja) | 2018-04-19 | 2023-10-20 | チェックメイト ファーマシューティカルズ， インコーポレイテッド | 合成ｒｉｇ－ｉ様受容体アゴニスト |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| US4009181A (en) * | 1973-01-22 | 1977-02-22 | Hoffmann-La Roche Inc. | Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof |
| US4057559A (en) * | 1973-10-01 | 1977-11-08 | American Home Products Corporation | Carbazole acetic acid derivatives |
| EP0234708B1 (fr) * | 1986-01-23 | 1991-02-27 | Merck Frosst Canada Inc. | Acides tétrahydrocarbazole 1-alcanoiques |
-
1987
- 1987-07-21 US US07/076,424 patent/US4808608A/en not_active Expired - Fee Related
-
1988
- 1988-07-11 NZ NZ225361A patent/NZ225361A/xx unknown
- 1988-07-12 IL IL87079A patent/IL87079A0/xx unknown
- 1988-07-13 EP EP88306392A patent/EP0300676A3/fr not_active Ceased
- 1988-07-19 ZA ZA885209A patent/ZA885209B/xx unknown
- 1988-07-20 DK DK404588A patent/DK404588A/da not_active Application Discontinuation
- 1988-07-20 AU AU19262/88A patent/AU611454B2/en not_active Expired - Fee Related
- 1988-07-20 PT PT88044A patent/PT88044B/pt not_active IP Right Cessation
- 1988-07-20 KR KR1019880009051A patent/KR890001987A/ko not_active Withdrawn
- 1988-07-21 JP JP63180475A patent/JPS6470462A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6470462A (en) | 1989-03-15 |
| IL87079A0 (en) | 1988-12-30 |
| EP0300676A3 (fr) | 1991-07-03 |
| PT88044B (pt) | 1995-03-01 |
| KR890001987A (ko) | 1989-04-07 |
| EP0300676A2 (fr) | 1989-01-25 |
| AU611454B2 (en) | 1991-06-13 |
| AU1926288A (en) | 1989-01-27 |
| DK404588D0 (da) | 1988-07-20 |
| NZ225361A (en) | 1991-06-25 |
| PT88044A (pt) | 1989-06-30 |
| US4808608A (en) | 1989-02-28 |
| ZA885209B (en) | 1989-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK404588D0 (da) | Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK314789D0 (da) | Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK284485A (da) | Indol-2-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK655288A (da) | Diarylstyrylquinolindisyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK406389A (da) | Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK85985A (da) | Carbamoyl- eller acyl-4-aza-5alfa-androst-1-en-3-on og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK287085D0 (da) | Triazolobenzodiazepin og farmaceutisk praeparat indeholdende en saadanforbindelse | |
| DK224589D0 (da) | Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK48790A (da) | Steroidforbindelse og farmaceutisk praeparat indeholden en saadan forbindelse | |
| DK287188D0 (da) | Cephalosporinforbindelser og farmaceutisk praeparat deraf | |
| DK537288D0 (da) | Tetrahydrocarbazolester og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK48886D0 (da) | Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK375584A (da) | Piperidinoquinazolinforbindelser og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK314386A (da) | Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne | |
| DK23088A (da) | Piperazinylpyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK404488D0 (da) | Cyclohept(b)indolalkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK191787D0 (da) | Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK258086A (da) | Substitueret hexahydroarylquinolin og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK680787D0 (da) | Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse | |
| DK60187A (da) | Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser | |
| DK669287D0 (da) | Farmaceutisk praerarat indeholdende en pyranoquinolinforbindelse | |
| DK330389D0 (da) | Tetrahydropyranonforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK513588A (da) | Thieno(2,3-b)furan-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| DK153842C (da) | Dihydrodibenzotiepinderivat og farmaceutisk praeparat indeholdende det | |
| DK53191D0 (da) | Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |